Search research articles
Contact Us
Filters
Showing results (1-10 of 132) with videos related to
Page
of 14
Sort By:
The Lancet. Child & Adolescent Health
|
August 19, 2018
The real impact of pneumococcal conjugate vaccines
Mark van der Linden
Plos One
|
September 5, 2015
Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013
Matthias Imöhl, Mark van der Linden
The Lancet Regional Health. Europe
|
June 6, 2022
Correction to "Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study"
Stephanie Perniciaro, Mark van der Linden
The Lancet. Infectious Diseases
|
March 28, 2018
Reassessing the 1 + 1 pneumococcal conjugate vaccine schedule
Stephanie Perniciaro, Mark van der Linden
The Lancet Regional Health. Europe
|
September 24, 2021
Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study
Stephanie Perniciaro, Mark van der Linden
Thorax
|
March 8, 2019
Herd protection or herding cats?
Mark van der Linden, Cynthia G Whitney
Emerging Infectious Diseases
|
September 19, 2018
Invasive Pneumococcal Disease in Refugee Children, Germany
Stephanie Perniciaro, Matthias Imöhl, Mark van der Linden
Plos One
|
January 17, 2020
Correction: Limited indirect effects of an infant pneumococcal vaccination program in an aging population
Mark van der Linden, Matthias Imöhl, Stephanie Perniciaro
BMC Infectious Diseases
|
May 6, 2015
Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era
Mark van der Linden, Stephanie Perniciaro, Matthias Imöhl
Plos One
|
August 2, 2019
Limited indirect effects of an infant pneumococcal vaccination program in an aging population
Mark van der Linden, Matthias Imöhl, Stephanie Perniciaro
Page
of 14
Search research articles
Search
Showing results (1-10 of 132) with videos related to
Sort By:
Page
of 14
The Lancet. Child & Adolescent Health
|
August 19, 2018
The real impact of pneumococcal conjugate vaccines
Mark van der Linden
Plos One
|
September 5, 2015
Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013
Matthias Imöhl, Mark van der Linden
The Lancet Regional Health. Europe
|
June 6, 2022
Correction to "Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study"
Stephanie Perniciaro, Mark van der Linden
The Lancet. Infectious Diseases
|
March 28, 2018
Reassessing the 1 + 1 pneumococcal conjugate vaccine schedule
Stephanie Perniciaro, Mark van der Linden
The Lancet Regional Health. Europe
|
September 24, 2021
Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study
Stephanie Perniciaro, Mark van der Linden
Thorax
|
March 8, 2019
Herd protection or herding cats?
Mark van der Linden, Cynthia G Whitney
Emerging Infectious Diseases
|
September 19, 2018
Invasive Pneumococcal Disease in Refugee Children, Germany
Stephanie Perniciaro, Matthias Imöhl, Mark van der Linden
Plos One
|
January 17, 2020
Correction: Limited indirect effects of an infant pneumococcal vaccination program in an aging population
Mark van der Linden, Matthias Imöhl, Stephanie Perniciaro
BMC Infectious Diseases
|
May 6, 2015
Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era
Mark van der Linden, Stephanie Perniciaro, Matthias Imöhl
Plos One
|
August 2, 2019
Limited indirect effects of an infant pneumococcal vaccination program in an aging population
Mark van der Linden, Matthias Imöhl, Stephanie Perniciaro
Page
of 14